Search Results
Dr. Esteva Discusses T-DM1 in HER2-Positive Breast Cancer
Dr. Louis Weiner Discusses the T-DM1 EMILIA Trial for HER2-Positive Breast Cancer
Dr. Esteva on Trastuzumab Biosimilar in Patients With HER2+ Breast Cancer
Dr. Esteva Discusses Neratinib Updates in HER2+ Breast Cancer
Dr. Esteva on Clinical Trial Design of Trastuzumab Biosimilar in HER2+ Breast Cancer
Dr. Tripathy Discusses Impact of T-DM1 in HER2+ Breast Cancer
Findings of a Biosimilar Trastuzumab Study in Patients With HER2-Positive Breast Cancer
Dr. Louis Weiner on the T-DM1 Mechanism of Action in HER2-Positive Breast Cancer
Frontline T-DM1 in HER2-Positive Metastatic Breast Cancer
Dr. Debu Tripathy Discusses the Updated EMILIA Trial Results for T-DM1
Dr. Hamilton on ONT-380/T-DM1 in HER2+ Breast Cancer
Dr. Julie Gralow Discusses T-DM1-Induced Thrombocytopenia